Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. ETF
  3. IINN
IINN logo

IINN

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

IINN News

Inspira Technologies Deploys ART100 System at Leading U.S. Hospital

Feb 18 2026Newsfilter

Inspira Technologies Showcases FDA-Cleared ART100 System

Feb 17 2026Newsfilter

Inspira Technologies Secures Major Procurement Approval

Feb 09 2026stocktwits

Inspira Technologies Secures Clalit Approval for ART100 System

Feb 09 2026Newsfilter

Inspira Technologies Validates HYLA System for Heart-Lung Surgery Market

Feb 03 2026Newsfilter

Inspira Technologies Achieves Major Milestone in U.S. Hospital

Jan 29 2026Newsfilter

Biotech Surge Post-Market: Inspira, MediciNova, and DiaMedica Therapeutics Among Top Performers

Dec 19 2025NASDAQ.COM

Inspira Secures Japanese Patent for Convertible Dual Lumen Cannula, Enhancing Market Position

Dec 09 2025Globenewswire

Inspira Technologies Secures Japanese Patent for Convertible Dual Lumen Cannula, Enhancing Market Position

Dec 09 2025Newsfilter

Inspira and Bites Join Forces to Integrate AI as a Fundamental Standard Throughout Inspira's Global Network

Oct 22 2025Newsfilter

Inspira Names Ex-Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from Prominent International Investment Firm

Oct 21 2025Newsfilter

Inspira Hires Ex-Johnson & Johnson Executive as Global Sales VP and Welcomes New Board Member from Prominent International Investment Firm

Oct 21 2025Newsfilter

Everything You Should Know About the Upgrade to Buy for Inspira Technologies OXY (IINN) Rating

Sep 22 2025NASDAQ.COM

Inspira Reports 97.3% Accuracy for HYLA™ Blood Sensor, Moving Closer to FDA Clearance Submission

Sep 11 2025Newsfilter

Inspira Secures U.S. Patent for ART500 Core Technology, Poised to Lead $20 Billion Market

Aug 22 2025Newsfilter

Inspira Obtains $27 Million Government Purchase Order for ART100 Systems, Payment Due in 2025

Aug 19 2025Newsfilter